| Product Code: ETC6078003 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Andorra Neurorehabilitation Market Overview |
3.1 Andorra Country Macro Economic Indicators |
3.2 Andorra Neurorehabilitation Market Revenues & Volume, 2021 & 2031F |
3.3 Andorra Neurorehabilitation Market - Industry Life Cycle |
3.4 Andorra Neurorehabilitation Market - Porter's Five Forces |
3.5 Andorra Neurorehabilitation Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Andorra Neurorehabilitation Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Andorra Neurorehabilitation Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Andorra Neurorehabilitation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Andorra |
4.2.2 Growing awareness about the importance of neurorehabilitation |
4.2.3 Technological advancements in neurorehabilitation therapies |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources in Andorra |
4.3.2 High costs associated with neurorehabilitation treatments |
4.3.3 Lack of skilled healthcare professionals specialized in neurorehabilitation in Andorra |
5 Andorra Neurorehabilitation Market Trends |
6 Andorra Neurorehabilitation Market, By Types |
6.1 Andorra Neurorehabilitation Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Andorra Neurorehabilitation Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Andorra Neurorehabilitation Market Revenues & Volume, By Neuro-Robotic Devices, 2021- 2031F |
6.1.4 Andorra Neurorehabilitation Market Revenues & Volume, By Non-Invasive Stimulators, 2021- 2031F |
6.1.5 Andorra Neurorehabilitation Market Revenues & Volume, By Brain-Computer Interfaces, 2021- 2031F |
6.2 Andorra Neurorehabilitation Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Andorra Neurorehabilitation Market Revenues & Volume, By Brain Stroke, 2021- 2031F |
6.2.3 Andorra Neurorehabilitation Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.2.4 Andorra Neurorehabilitation Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.5 Andorra Neurorehabilitation Market Revenues & Volume, By Spinal Cord Injury, 2021- 2031F |
6.2.6 Andorra Neurorehabilitation Market Revenues & Volume, By Traumatic Brain Injury, 2021- 2031F |
6.2.7 Andorra Neurorehabilitation Market Revenues & Volume, By Cerebral Palsy, 2021- 2031F |
6.3 Andorra Neurorehabilitation Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Andorra Neurorehabilitation Market Revenues & Volume, By Rehabilitation Centers, 2021- 2031F |
6.3.3 Andorra Neurorehabilitation Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Andorra Neurorehabilitation Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Andorra Neurorehabilitation Market Import-Export Trade Statistics |
7.1 Andorra Neurorehabilitation Market Export to Major Countries |
7.2 Andorra Neurorehabilitation Market Imports from Major Countries |
8 Andorra Neurorehabilitation Market Key Performance Indicators |
8.1 Patient satisfaction rates with neurorehabilitation services |
8.2 Number of collaborations with international neurorehabilitation centers for knowledge exchange |
8.3 Percentage increase in the utilization of advanced neurorehabilitation technologies |
8.4 Average length of stay in neurorehabilitation facilities |
8.5 Number of research studies or clinical trials conducted in the field of neurorehabilitation in Andorra |
9 Andorra Neurorehabilitation Market - Opportunity Assessment |
9.1 Andorra Neurorehabilitation Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Andorra Neurorehabilitation Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Andorra Neurorehabilitation Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Andorra Neurorehabilitation Market - Competitive Landscape |
10.1 Andorra Neurorehabilitation Market Revenue Share, By Companies, 2024 |
10.2 Andorra Neurorehabilitation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here